Cite Filings / RNAC / 0001213900-21-065502
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Cartesian Therapeutics, Inc. · Filed 2021-12-15 · Acc 0001213900-21-065502

Documents 1

  • SC 13D/A Beneficial Ownership Report , ea152434-13da8spring_select.htm

Around this filing

  • 2021-12-27 SC 13D/A Beneficial Ownership Report
  • 2021-12-15 SC 13D/A Beneficial Ownership Report
  • 2021-12-14 4 Chief Medical Officer sold 4,083 shares at $2.99 ($12,196)
  • 2021-12-14 4 Chief Scientific Officer sold 4,370 shares at $2.99 ($13,053)
  • 2021-12-14 4 Chief Operations Officer sold 4,370 shares at $2.99 ($13,053)
  • 2021-12-14 4 President and CEO sold 17,196 shares at $2.99 ($51,363)
  • 2021-05-27 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading ea152434-13da8spring_select.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…